Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer

NCT03051906 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

BIOLOGICAL: Durvalumab
BIOLOGICAL: Cetuximab
RADIATION: Intensity modulated radiation therapy (IMRT)

Sponsor

Azienda Ospedaliero-Universitaria Careggi